FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287447402> ?p ?o ?g. }

• W4287447402 abstract "Dear Editor, Reports of cutaneous side effects due to a COVID-19 vaccine have increased with the expansion of vaccinations. Cutaneous side effects are more common in women, and the most frequent skin manifestations are delayed large local reactions, local injection site reactions, urticaria, and herpes zoster.1 There are few reports of a lichenoid reaction. We report a case of linear lichen planus triggered by the Pfizer-BioNTech COVID-19 vaccine. A 57-year-old Japanese woman suffered from linear erythematous-brown papules along Blaschko's lines on her left upper extremity (Figure 1a). She had no personal or family history of inflammatory skin conditions. Apart from COVID-19 vaccination, she had not been exposed to any other medications, herbal therapy, or other vaccinations in the weeks or months prior to eruption developing. She noted that (i) she had received the third dose of the Pfizer-BioNTech COVID-19 vaccination at her left upper extremity 2 weeks earlier, and (ii) she had no skin symptoms after the first and second Pfizer-BioNTech COVID-19 vaccinations. The routine blood test results were unremarkable, including negative serology for hepatitis C. A skin biopsy revealed hyperkeratosis, basal liquefaction, Civatte bodies, and interface dermatitis with a perivascular lymphocytic infiltration, confirming the histopathological diagnosis of lichenoid reaction (Figure 1b,c). Although lichen striatus was considered as a differential diagnosis based on the clinical findings, the lack of lymphocytic infiltration around the eccrine glands, which is common in lichen striatus, led to the diagnosis of linear lichen planus (LLP). Approximately 6 weeks after the start of treatment with topical corticosteroids, the skin lesions improved with leaving mild pigmentation. To the best of our knowledge, LLP after COVID-19 vaccination has not been reported. Although there have been no reports of LLP, there are reports of nine patients with lichen planus (LP) after COVID-19 vaccination.2-9 Because LLP is a variant of LP, we reviewed 10 patients including our patient (Table 1). Nine of the 10 patients were female (90%). The median age was 56.0 years (range 29–64 years). The vaccine in five of the eight patients for whom vaccine-type details were available (62.5%) was Pfizer BioNTech's COVID-19 vaccine. Four of the seven patients (57.1%) for whom details of the vaccination administration were available developed the eruption after the first dose; two patients after the second dose (28.6%), and only our patient after the third dose. Of the nine patients described in detail, LP lesions developed within 6 days from vaccination (4 patients; 44.4%), one-week (2 patients; 22.2%) or two-week post-vaccination (3 patients; 33.3%). These results suggest that the appearance of LP and LLP might develop later than other cutaneous reactions such as itching and urticaria. In addition, in some individuals, the LP and LLP skin reaction may occur after a second- or third-dose vaccination without appearing after earlier COVID-19 vaccinations. Lichenoid reactions are not unique to the COVID-19 vaccinations because LP-like eruptions have been reported with other vaccinations such as hepatitis B and influenza.10 However, dermatologists need to be aware of the possibility of lichen reaction after COVID-19 vaccinations, and careful interviewing of the patient is important. The authors declare no conflicts of interest. Consent is obtained from our patients for the use of the images and for the reporting." @default.
• W4287447402 created "2022-07-25" @default.
• W4287447402 creator A5015443172 @default.
• W4287447402 creator A5019667524 @default.
• W4287447402 creator A5020284953 @default.
• W4287447402 creator A5037142541 @default.
• W4287447402 creator A5042799216 @default.
• W4287447402 creator A5054498346 @default.
• W4287447402 creator A5086634951 @default.
• W4287447402 date "2022-07-25" @default.
• W4287447402 modified "2023-09-26" @default.
• W4287447402 title "Linear lichen planus after <scp>COVID</scp> ‐19 vaccination" @default.
• W4287447402 cites W3137856521 @default.
• W4287447402 cites W3178912000 @default.
• W4287447402 cites W3181634133 @default.
• W4287447402 cites W3199498860 @default.
• W4287447402 cites W3200012379 @default.
• W4287447402 cites W3201793272 @default.
• W4287447402 cites W4200311310 @default.
• W4287447402 cites W4211003242 @default.
• W4287447402 cites W4220820953 @default.
• W4287447402 doi "https://doi.org/10.1111/ajd.13902" @default.
• W4287447402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35877179" @default.
• W4287447402 hasPublicationYear "2022" @default.
• W4287447402 type Work @default.
• W4287447402 citedByCount "3" @default.
• W4287447402 countsByYear W42874474022022 @default.
• W4287447402 countsByYear W42874474022023 @default.
• W4287447402 crossrefType "journal-article" @default.
• W4287447402 hasAuthorship W4287447402A5015443172 @default.
• W4287447402 hasAuthorship W4287447402A5019667524 @default.
• W4287447402 hasAuthorship W4287447402A5020284953 @default.
• W4287447402 hasAuthorship W4287447402A5037142541 @default.
• W4287447402 hasAuthorship W4287447402A5042799216 @default.
• W4287447402 hasAuthorship W4287447402A5054498346 @default.
• W4287447402 hasAuthorship W4287447402A5086634951 @default.
• W4287447402 hasBestOaLocation W42874474021 @default.
• W4287447402 hasConcept C142724271 @default.
• W4287447402 hasConcept C16005928 @default.
• W4287447402 hasConcept C22070199 @default.
• W4287447402 hasConcept C2775934546 @default.
• W4287447402 hasConcept C2779915019 @default.
• W4287447402 hasConcept C2780439664 @default.
• W4287447402 hasConcept C2780801072 @default.
• W4287447402 hasConcept C71924100 @default.
• W4287447402 hasConceptScore W4287447402C142724271 @default.
• W4287447402 hasConceptScore W4287447402C16005928 @default.
• W4287447402 hasConceptScore W4287447402C22070199 @default.
• W4287447402 hasConceptScore W4287447402C2775934546 @default.
• W4287447402 hasConceptScore W4287447402C2779915019 @default.
• W4287447402 hasConceptScore W4287447402C2780439664 @default.
• W4287447402 hasConceptScore W4287447402C2780801072 @default.
• W4287447402 hasConceptScore W4287447402C71924100 @default.
• W4287447402 hasIssue "4" @default.
• W4287447402 hasLocation W42874474021 @default.
• W4287447402 hasLocation W42874474022 @default.
• W4287447402 hasLocation W42874474023 @default.
• W4287447402 hasOpenAccess W4287447402 @default.
• W4287447402 hasPrimaryLocation W42874474021 @default.
• W4287447402 hasRelatedWork W1516511504 @default.
• W4287447402 hasRelatedWork W1970810397 @default.
• W4287447402 hasRelatedWork W2019211255 @default.
• W4287447402 hasRelatedWork W2066399773 @default.
• W4287447402 hasRelatedWork W2085895414 @default.
• W4287447402 hasRelatedWork W3113816815 @default.
• W4287447402 hasRelatedWork W3134882920 @default.
• W4287447402 hasRelatedWork W4200066940 @default.
• W4287447402 hasRelatedWork W4385737098 @default.
• W4287447402 hasRelatedWork W3121372422 @default.
• W4287447402 hasVolume "63" @default.
• W4287447402 isParatext "false" @default.
• W4287447402 isRetracted "false" @default.
• W4287447402 workType "article" @default.